Seeking Alpha Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 88
- Sources here
- 16
- Companies here
- 6
Active search
88 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?
Clover Health Investments, Corp. has already reported its second-quarter 2026 results, posting revenue of US$743.17 million versus US$477.62 million a year earlier and moving from a net loss of US$10.58 million to net income of US$28 million. Alongside this shift to profitability, the company …
The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call
The 5 Most Interesting Analyst Questions From Clover Health's Q2 Earnings Call Clover Health's second quarter results were met with a positive market reaction, driven by strong Medicare Advantage membership growth and improved profitability. Management credited the quarter's performance to the expansion of its …
The Lovesac Company (NASDAQ:LOVE) Receives Average Recommendation of "Moderate Buy" from Analysts
The Lovesac Company (NASDAQ:LOVE) has received an average recommendation of "Moderate Buy" from analysts, with four out of five rating it a buy and one a sell. The average 12-month price target is $22.67, exceeding the current share price of $17.65. Despite a slight …
Clover Health Interim CFO Joseph Clay Thornton Awarded 54,347 RSUs with Four-Year Vesting
Clover Health's Interim CFO, Joseph Clay Thornton, was granted 54,347 Restricted Stock Units (RSUs) of Class A Common Stock. These RSUs, valued at $0, will vest over a four-year period, with 25% vesting on August 12, 2027, and the remainder in quarterly installments, fully …
Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth
Key Points Interested in Clover Health Investments, Corp.? Here are five stocks we like better. Clover Health is targeting its first full year of GAAP profitability in 2026, alongside approximately 50% membership growth, after reporting sustained adjusted EBITDA profitability and improved operating leverage. The …
Clover Health CEO Andrew Toy sells $408,260 in stock By Investing.com
Clover Health CEO Andrew Toy sold 87,798 shares of the company's Class A Common Stock for approximately $408,260. This "sell to cover" transaction was not discretionary but mandated to fulfill tax withholding obligations tied to previously granted restricted stock units. Following this, Mr. Toy …
CLOV (Nasdaq: CLOV) discloses planned 85,704-share sale by Andrew Toy
Clover Health Investments, Corp. (Nasdaq: CLOV) has disclosed a planned sale of 85,704 shares of Class A common stock by Andrew Toy through Morgan Stanley Smith Barney LLC, valued at approximately $391,667.28. These shares originate from Restricted Stock Units acquired as compensation on August …
Clover Health (CLOV) CEO Andrew Toy sells 87,798 shares for tax withholding
Clover Health CEO Andrew Toy sold 87,798 shares of Class A Common Stock for $408K on August 10, 2026, at a weighted average price of $4.65 per share. This sale was non-discretionary and conducted solely to cover tax withholding obligations associated with the final …
Dimensional Fund Advisors LP Lowers Stake in The Lovesac Company $LOVE
Dimensional Fund Advisors LP reduced its holdings in The Lovesac Company (NASDAQ:LOVE) by 13.1% in the first quarter, selling 88,758 shares but still retaining 587,699 shares valued at $8.68 million. Despite this, institutional investors and hedge funds own a significant 91.32% of the company's …
Lovesac Co (LOVE) Earnings Forecast: Future EPS & Revenue Growth Estimates
Lovesac Co (LOVE) has an earnings forecast score of 8.33, ranking 3rd in the Household Goods industry, with an average price target of $29.00 from analysts. The stock is currently rated as a "Buy" by 6 analysts, who predict a 35.62% upside. Expected revenue …
Kanen Wealth Management LLC Takes $8.06 Million Position in The Lovesac Company $LOVE
Kanen Wealth Management LLC has acquired a new stake of 545,963 shares in The Lovesac Company (NASDAQ:LOVE) worth approximately $8.06 million, making it their 10th largest holding. Institutional ownership in Lovesac is high at 91.32%, with other firms also increasing their positions. Analysts maintain …
Anson Funds Management LP Has $17.49 Million Holdings in The Lovesac Company $LOVE
Anson Funds Management LP reduced its stake in The Lovesac Company (NASDAQ:LOVE) by 13.6% in the first quarter, selling 186,679 shares but still holding 1.18 million shares valued at $17.49 million, representing an 8.01% stake. Despite this, Lovesac's recent quarterly revenue of $138.2 million …
Lovesac Co (LOVE) Financial Health: Profitability & Balance Sheet Analysis
Lovesac Co (LOVE) holds a financial score of 7.35, placing it 10th out of 23 companies in the Household Goods industry, indicating stable financial health and average operating efficiency. The company's latest quarterly revenue was $138.20 million, a 0.13% year-over-year decrease, with net profit …